Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

radioimmunotherapy

  • You have access
    Efficient 1-Step Radiolabeling of Monoclonal Antibodies to High Specific Activity with 225Ac for α-Particle Radioimmunotherapy of Cancer
    William F. Maguire, Michael R. McDevitt, Peter M. Smith-Jones and David A. Scheinberg
    Journal of Nuclear Medicine September 1, 2014, 55 (9) 1492-1498; DOI: https://doi.org/10.2967/jnumed.114.138347
  • You have access
    Tumor-Absorbed Dose Predicts Progression-Free Survival Following 131I-Tositumomab Radioimmunotherapy
    Yuni K. Dewaraja, Matthew J. Schipper, Jincheng Shen, Lauren B. Smith, Jure Murgic, Hatice Savas, Ehab Youssef, Denise Regan, Scott J. Wilderman, Peter L. Roberson, Mark S. Kaminski and Anca M. Avram
    Journal of Nuclear Medicine July 1, 2014, 55 (7) 1047-1053; DOI: https://doi.org/10.2967/jnumed.113.136044
  • You have access
    Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine
    Rebecca A. Herbertson, Niall C. Tebbutt, Fook-Thean Lee, Sanjeev Gill, Bridget Chappell, Tina Cavicchiolo, Tim Saunder, Graeme J. O’Keefe, Aurora Poon, Sze Ting Lee, Roger Murphy, Wendie Hopkins, Fiona E. Scott and Andrew M. Scott
    Journal of Nuclear Medicine April 1, 2014, 55 (4) 534-539; DOI: https://doi.org/10.2967/jnumed.113.132761
  • You have access
    213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma
    Michel Chérel, Sébastien Gouard, Joëlle Gaschet, Catherine Saï-Maurel, Frank Bruchertseifer, Alfred Morgenstern, Mickael Bourgeois, Jean-François Gestin, Françoise Kraeber Bodéré, Jacques Barbet, Philippe Moreau and François Davodeau
    Journal of Nuclear Medicine September 1, 2013, 54 (9) 1597-1604; DOI: https://doi.org/10.2967/jnumed.112.111997
  • You have access
    The Role of p53 in Combination Radioimmunotherapy with 64Cu-DOTA-Cetuximab and Cisplatin in a Mouse Model of Colorectal Cancer
    Yunjun Guo, Jesse J. Parry, Richard Laforest, Buck E. Rogers and Carolyn J. Anderson
    Journal of Nuclear Medicine September 1, 2013, 54 (9) 1621-1629; DOI: https://doi.org/10.2967/jnumed.112.118539
  • You have access
    The Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies Changes in Relation to Tumor Histology over Time in a Syngeneic Rat Colon Carcinoma Model
    Anders Örbom, Sophie E. Eriksson, Erika Elgström, Tomas Ohlsson, Rune Nilsson, Jan Tennvall and Sven-Erik Strand
    Journal of Nuclear Medicine August 1, 2013, 54 (8) 1404-1410; DOI: https://doi.org/10.2967/jnumed.112.117028
  • You have access
    Ex Vivo Activity Quantification in Micrometastases at the Cellular Scale Using the α-Camera Technique
    Nicolas Chouin, Sture Lindegren, Sofia H.L. Frost, Holger Jensen, Per Albertsson, Ragnar Hultborn, Stig Palm, Lars Jacobsson and Tom Bäck
    Journal of Nuclear Medicine August 1, 2013, 54 (8) 1347-1353; DOI: https://doi.org/10.2967/jnumed.112.113001
  • You have access
    Radioimmunotherapy with 177Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas
    Flavio Forrer, Catharina Oechslin-Oberholzer, Benedetta Campana, Richard Herrmann, Helmut R. Maecke, Jan Mueller-Brand and Andreas Lohri
    Journal of Nuclear Medicine July 1, 2013, 54 (7) 1045-1052; DOI: https://doi.org/10.2967/jnumed.112.115170
  • You have access
    Treatment of Triple-Negative Breast Cancer Using Anti-EGFR–Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor
    Fares Al-Ejeh, Wei Shi, Mariska Miranda, Peter T. Simpson, Ana Cristina Vargas, Sarah Song, Adrian P. Wiegmans, Alex Swarbrick, Alana L. Welm, Michael P. Brown, Georgia Chenevix-Trench, Sunil R. Lakhani and Kum Kum Khanna
    Journal of Nuclear Medicine June 1, 2013, 54 (6) 913-921; DOI: https://doi.org/10.2967/jnumed.112.111534
  • You have access
    Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer
    Rafke Schoffelen, Winette T.A. van der Graaf, Robert M. Sharkey, Gerben M. Franssen, William J. McBride, Chien-Hsing Chang, Desirée L. Bos, David M. Goldenberg, Wim J.G. Oyen and Otto C. Boerman
    Journal of Nuclear Medicine December 1, 2012, 53 (12) 1926-1932; DOI: https://doi.org/10.2967/jnumed.112.106278

Pages

  • Previous
  • 1
  • 2
  • 3
  • 4
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire